Investing.com - Genmab AS reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Genmab AS announced earnings per share of $0.1108 on revenue of $334.21M. Analysts polled by Investing.com anticipated EPS of $0.1253 on revenue of $293.35M.
Genmab AS shares are down 9.74% from the beginning of the year and are trading at $36.70 , down-from-52-week-high.They are under-performing the Nasdaq which is up 4.48% from the start of the year.
Genmab AS follows other major sector earnings this month
Genmab AS's report follows an earnings beat by Ping An Insurance Company of China on Wednesday, February 3, 2021, who reported EPS of $0.6308 on revenue of $26.15B, compared to forecasts EPS of $0.6304 on revenue of $24.08B.
SoftBank Group had beat expectations on Monday, February 8, 2021 with fourth quarter EPS of $2.97 on revenue of $14.41B, compared to forecast for EPS of $0.0374 on revenue of $12.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar